
Real Messenger, Rectitude, Allogene Therapeutics, Creative Media & Community Trust Corporation, RedCloud, Sidus Space, and Replimune Group are the seven Penny stocks to watch today, according to MarketBeat’s stock screener tool. Penny stocks are low-priced shares of small public companies that typically trade for less than $5 per share (the SEC’s cutoff) and are often listed on over-the-counter markets or small-cap exchanges. They tend to have low liquidity, wide bid–ask spreads and high price volatility, making them higher-risk investments prone to manipulation. These companies had the highest dollar trading volume of any Penny stocks within the last several days.
Real Messenger (RMSG)
Read Our Latest Research Report on RMSG
Rectitude (RECT)
Read Our Latest Research Report on RECT
Allogene Therapeutics (ALLO)
Allogene Therapeutics, Inc., a clinical stage immuno-oncology company, develops and commercializes genetically engineered allogeneic T cell therapies for the treatment of cancer. It develops, manufactures, and commercializes UCART19, an allogeneic chimeric antigen receptor (CAR) T cell product candidate for the treatment of pediatric and adult patients with R/R CD19 positive B-cell acute lymphoblastic leukemia (ALL).
Read Our Latest Research Report on ALLO
Creative Media & Community Trust Corporation (CMCT)
Creative Media & Community Trust Corp. is a real estate investment trust that seeks to own, operate, and develop premier multifamily and creative office assets in vibrant and emerging communities throughout the United States. It operates through the following segments: Office, Hotel, and Lending.
Read Our Latest Research Report on CMCT
RedCloud (RCT)
We have developed and operate the RedCloud platform (the “Platform”), that facilitates the trading of everyday consumer supplies of fast-moving consumer goods (“FMCG”) products across business supply chains. We believe the Platform solves a decades old problem of how to unlock and enable access of key purchase and sales data between brands, distributors and retailers in high growth consumer markets.
Read Our Latest Research Report on RCT
Sidus Space (SIDU)
Sidus Space, Inc., a space-as-a-service company, engages in the design, manufacture, launch, and data collection of commercial satellite worldwide. Its space services include satellite/space hardware manufacturing; Low Earth Orbit (LEO) launch and deployment services; and space-based geospatial intel, imagery, and data analytics.
Read Our Latest Research Report on SIDU
Replimune Group (REPL)
Replimune Group, Inc., a clinical-stage biotechnology company, focuses on the development of oncolytic immunotherapies to treat cancer. The company's proprietary tumor-directed oncolytic immunotherapy product candidates are designed and intended to activate the immune system against cancer. Its lead product candidate is RP1, a selectively replicating version of HSV-1 that expresses GALV-GP R(-) and human GM-CSF, which is in Phase I/II clinical trials for a range of solid tumors; and that has completed Phase II clinical trials for treating cutaneous squamous cell carcinoma.
Read Our Latest Research Report on REPL
Read More
- MarketBeat’s Top Five Stocks to Own in April 2026
- AI, Satellites and Staples: Insiders Are Buying and Selling 3 Big Names
- These are the 3 Biggest AI Winners and Losers of 2026
- U.S.-Iran Ceasefire: Short Interest Surges for This Defense ETF
- 3 Retail Stocks to Watch for a Post-Tax-Day Bump
- 5 Stocks Leading the Market’s Rebound: The AI Connectivity Trade
